1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Venezuela Pharmaceuticals and Healthcare Report Q1 2017

Venezuela Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 96 pages

Includes 3 FREE quarterly updates


BMI View:

The activity of multinational pharmaceutical companies in Venezuela will remain limited over the coming quarters. Venezuela’s economic crisis has had a direct impact on healthcare spending, as outof- pocket spending is a primary source of funding. We forecast that the worst part of the recession is yet to play out and do not anticipate a significant recovery in the healthcare sector anytime soon. The tough operating environment, with some drugmakers being unable to collect payments owed, will serve to further dissuade additional investments in the short term.

Headline Expenditure Projections



- Pharmaceuticals: VEF88.7bn (USD3.0bn) in 2015 to VEF259.6bn (USD951mn) in 2016; +192.6% in local currency terms and -68.6% in US dollar terms. Forecast has been maintained from last quarter in local currency terms.

- Healthcare: VEF297.3bn (USD10.2bn) in 2015 to VEF838.7bn (USD12.9bn) in 2016; +182.1% in local currency terms and +27.0% in US dollar terms. Forecast has been maintained from last quarter in local currency terms.

Table Of Contents

Venezuela Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Venezuela 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2012-2020) 12
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts, Local Currency (Venezuela 2014-2020) 29
Industry Risk/Reward Index 30
Americas Risk/Reward Index 30
Venezuela Risk/Reward Index 35
Rewards 35
Risks 36
Regulatory Review 37
Intellectual Property Issues 37
Pricing Regime 41
Reimbursement Regime 43
Market Overview 44
Healthcare Sector 44
Table: Healthcare Resources (Venezuela 2010-2015) 47
Table: Healthcare Personnel (Venezuela 2010-2015) 47
Table: Healthcare Activity (Venezuela 2010-2015) 48
Research and Development 49
Clinical Trials 50
Epidemiology 51
Competitive Landscape 54
Research-Based Industry 54
Generic Drugmakers 56
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 59
Company Profile 61
Boehringer Ingelheim 61
Calox International 63
Elmor 65
GlaxoSmithKline 67
Grupo Farma 70
Merck and Co 72
Novartis 75
Pfizer 78
Sanofi 81
Strides Latina (Sumifarma) 83
Demographic Forecast 85
Demographic Outlook 85
Table: Population Headline Indicators (Venezuela 1990-2025) 86
Table: Key Population Ratios (Venezuela 1990-2025) 86
Table: Urban/Rural Population and Life Expectancy (Venezuela 1990-2025) 87
Table: Population By Age Group (Venezuela 1990-2025) 87
Table: Population By Age Group % (Venezuela 1990-2025) 88
Glossary 90
Methodology 92
Pharmaceutical Expenditure Forecast Model 92
Healthcare Expenditure Forecast Model 92
Notes On Methodology 93
Risk/Reward Index Methodology 94
Index Overview 95
Table: Pharmaceutical Risk/Reward Index Indicators 95
Indicator Weightings 96

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.